The Fox Chase Chemical Diversity Center, Inc. (FCCDC)

 

The Fox Chase Chemical Diversity Center Announces it Has Been Awarded an NIH Grant from the National Institution of Aging Entitled "Therapeutics Targeting TDP-43 to Treat Alzheimer's Disease and Related Disorders"

 

Doylestown, PA. June 25, 2021 - FCCDC is pleased to announce that it was been awarded a grant from the National Institution of Aging of the National Institutes of Health entitled "Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders" (U01AG068823).